JDVNX | VIVAX | JDVNX / VIVAX | |
Total Expense Ratio | 0.60 | 0.17 | 353% |
Annual Report Gross Expense Ratio | 0.61 | 0.17 | 359% |
Fund Existence | 16 years | 33 years | - |
Gain YTD | 7.545 | 5.603 | 135% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18B | 189B | 10% |
Annual Yield % from dividends | 1.04 | 2.06 | 51% |
Returns for 1 year | -0.36 | 11.40 | -3% |
Returns for 3 years | 18.87 | 34.39 | 55% |
Returns for 5 years | 50.67 | 79.11 | 64% |
Returns for 10 years | 45.67 | 114.51 | 40% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XMLV | 62.64 | 0.30 | +0.48% |
Invesco S&P MidCap Low Volatility ETF | |||
JEPQ | 54.16 | 0.18 | +0.33% |
JPMorgan Nasdaq Equity Premium Inc ETF | |||
JULW | 37.28 | 0.06 | +0.16% |
AllianzIM US Large Cap Buffer20 Jul ETF | |||
VABS | 24.45 | -0.01 | -0.04% |
Virtus Newfleet ABS/MBS ETF | |||
BIS | 16.74 | -0.15 | -0.89% |
ProShares UltraShort Nasdaq Biotech |